S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma
Yanmeng Wang(Xi'an Jiaotong University), Eline Menu(Vrije Universiteit Brussel)
Cited by 11
Related Papers
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
|Oncotarget|2015|147
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
|Journal of Experimental & Clinical Cancer Research|2022|31
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis
|The Journal of Pathology|2023|28
Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the <scp>JAK</scp>‐<scp>STAT</scp> pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
|British Journal of Haematology|2014|14
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape
|Journal of Hematology & Oncology|2025|4